Preeclampsia: new-onset gestational hypertension with proteinuria or end-organ dysfunction
Superimposed preeclampsia: preeclampsia that occurs in a patient with chronic hypertension
HELLP syndrome
A life-threatening form of preeclampsia characterized by Hemolysis, Elevated Liver enzymes, and Low Platelets
May occur without hypertension or proteinuria
Occurrence of new-onset hypertension, proteinuria, or end-organ dysfunction at < 20 weeks’ gestation is suggestive of gestational trophoblastic disease.
Eclampsia: new-onset seizures (tonic-clonic, focal, or multifocal) in the absence of other causes ; a convulsive manifestation of hypertensive pregnancy disorders
Epidemiology
Etiology
Pathophysiology
Clinical features
Diagnostics
Treatment
Antihypertensives in pregnancy
Antihypertensives for urgent blood pressure control in pregnancy
Parenteral labetalol (avoid in patients with contraindications to β-blockers)
Should be administered with care in patients with renal insufficiency
Monitoring
Monitor all patients for signs of hypermagnesemia (e.g., decreased deep tendon reflexes, respiratory depression).
Signs of hypermagnesemia: Administer calcium gluconate (see “Hypermagnesemia” for clinical features and more information on management of hypermagnesemia).
Aspirin for preeclampsia prophylaxis
Indications
≥ 1 high-risk feature or ≥ 2 moderate-risk factors for preeclampsia.
Regimen
Initiate low-dose aspirin between 12–20 weeks’ gestation (optimally before 16 weeks)